OncoZenge: Down, but not out - Redeye

Redeye provides a research update following the Pharmanovia’s decision to discontinue the partnership with OncoZenge and not sign a definite commercial agreement. On the back end of this, we make some adjustments to our assumptions and estimates regarding financing, partnership deals and sales model.

Länk till analysen i sin helhet: https://www.redeye.se/research/1061007/oncozenge-down-but-not-out?utm_source=finwire&utm_medium=RSS